AXDX
Accelerate Diagnostics Inc
Halal Rating :
Last Price
$1.08
Last updated:
Market Cap
-
7D Change
-4.42%
1 Year Change
-13.6%
Company Overview
Industries
Exchange
Next Earnings Date
Accelerate Diagnostics Inc is a medical device company focused on developing and commercializing innovative systems for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company's primary product is the Accelerate Pheno™ system, which provides rapid diagnosis and antibiotic susceptibility results for patients with bloodstream infections.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.98m | $15.19m | - | $3.59m | 0.00% | 23.66% |
| June 30, 2024 | $2.99m | $14.18m | - | $2.59m | 0.00% | 18.26% |
| March 31, 2024 | $2.92m | $15.53m | - | $2.45m | 0.00% | 15.78% |
Company Impact
Help us evaluate Accelerate Diagnostics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.